Splitomicin
Splitomicin is a cell-permeable lactone derived from naphthol and known to be a potent selective inhibitor of Sir2 (silent information regulator 2) and HDAC. Splitomicin inhibits the NAD+-dependent deacetylase activity of Sir2 in vitro. It increases the levels of cyclic AMP by inhibiting the activity of cyclic AMP phosphodiesterase, interferes with mobilization of intracellular Ca+2 and ATP release.
Product Specifications
CAS Number
5690-03-9
Product Name Alternative
Splitomicin
Purity
>98% (HPLC)
Solubility
In Vitro: DMSO : 100 mg/mL (504.49 mM)
Smiles
O=C1CCc2c3ccccc3ccc2O1
Molecular Formula
C13H10O2
Molecular Weight
198.22
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
1H-benzo[f]chromen-3 (2H) -one
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
032406-HRP 200 µL
BAD, phosphorylated (S91) (BAD, BBC6, BCL2L8, Bcl2 antagonist of cell death, Bcl-2-binding component 6, Bcl-2-like protein 8, Bcl-XL/Bcl-2-associated death promoter) (Azide free) (HRP) discontinued
Sign In for Pricing
View Details 
YDA82128-01 50 mg
(E) -2- (4-Methylphenyl) ethene-1-sulfonyl chloride
Sign In for Pricing
View Details YDA82128-02 0.5 g
(E) -2- (4-Methylphenyl) ethene-1-sulfonyl chloride
Sign In for Pricing
View Details 
49396061 1.0 µg DNA
UTP3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details